Pick 2–10 funds, stocks or ETFs to see their returns, risk, costs and highlights on one page
| Fund | ||||||||
|---|---|---|---|---|---|---|---|---|
| WEGE3 | +2.25% | +12.00% | +0.39% | −2.01% | +8.20% | +12.24% | +22.23% | +39.53% |
| TEMxCH | +28.17% | −0.40% | −0.53% | −5.81% | −1.33% | +9.80% | +29.32% | +57.66% |
| K-SEMQ | +19.93% | +0.27% | −2.21% | −7.17% | −1.89% | +2.30% | +18.87% | +60.61% |
| KKP EMXCN-H-M | +22.91% | +1.81% | −1.40% | −7.71% | +0.08% | +2.27% | +23.75% | +49.18% |
| TISCOGEM | +1.71% | −0.45% | −3.65% | −5.32% | −3.72% | −4.23% | −1.25% | +20.37% |
* Fewer than 12 months: the year the fund started reporting NAV, or the current year
Counts only the top holdings with available data, not the whole portfolio · Pick a pair below for details
Excludes WEGE3: money market or bond funds, or no holdings data yet
| K-SEMQ | KKP EMXCN-H-M | |
|---|---|---|
| Held by both | ||
| 10.70% | 19.24% | |
| 10.17% | 10.46% | |
| 8.00% | 7.27% | |
| 4.14% | 2.23% | |
| 2.40% | 0.97% | |
| 1.99% | 0.83% | |
| Only in K-SEMQ | ||
| BYD | 2.74% | N/A |
| 2.37% | N/A | |
| WuXi Biologics | 2.22% | N/A |
| 2.14% | N/A | |
| Only in KKP EMXCN-H-M | ||
| N/A | 1.16% | |
| SK Square | N/A | 0.78% |
| N/A | 0.74% | |
30 Dec 2025 → 29 Oct 2026
| Fund | Return per year | Volatility per year | Sharpe |
|---|---|---|---|
| TEMxCH | +28.17% | 25.19% | 1.12 |
| KKP EMXCN-H-M | +22.91% | 30.66% | 0.75 |
| K-SEMQ | +19.93% | 27.56% | 0.72 |
| TISCOGEM | +1.71% | 17.98% | 0.10 |
| WEGE3 | +2.25% | 31.88% | 0.07 |
Sharpe here = annual return ÷ annual volatility, without deducting the risk-free rate, calculated from NAV over the selected period · Periods shorter than 1 year use the cumulative return instead of the annual return
| Drag a column header to reorder | WEGE3 | TEMxCH | K-SEMQ | KKP EMXCN-H-M | TISCOGEM |
|---|---|---|---|---|---|
Fund details | |||||
| Fund size | N/A | 1,355 million | 4,373 million | N/A | 28.32 million |
| Inception date | N/A | 6 Jun 2024 | 22 Mar 2017 | 9 Feb 2024 | 7 Apr 2017 |
| Master fund | N/A | กองทุน Invesco Emerging Markets ex-China Equity | Templeton Emerging Markets Fund | iShares MSCI Emerging Markets ex China ETF | กองทุน Vanguard FTSE Emerging Markets ETF |
| Dividend policy | N/A | Does not pay | Does not pay | Does not pay | Does not pay |
Risk and currency hedging | |||||
| Risk level | N/A | 6 | 6 | 6 | 6 |
| Hedging policy | N/A | Hedged at the manager's discretion | Hedged at the manager's discretion | Almost fully hedged | Hedged at the manager's discretion |
| Share hedged | N/A | 92.55% | 93.73% | 101.57% | 94.72% |
Minimum purchase and redemption | |||||
| First purchase | N/A | No minimum | 500 THB | No minimum | No minimum |
| Subsequent purchase | N/A | No minimum | 500 THB | No minimum | No minimum |
| Redemption (amount) | N/A | No minimum | 500 THB | No minimum | No minimum |
| Redemption (units) | N/A | No minimum | No minimum | No minimum | No minimum |
| Balance (amount) | N/A | No minimum | 50 THB | No minimum | No minimum |
| Balance (units) | N/A | 100 units | No minimum | No minimum | 100 units |
Order cut-off and redemption payment | |||||
| Buy before | N/A | 15:30 | 15:30 | 15:30 | 15:30 |
| Redeem before | N/A | 15:30 | 14:30 | 15:30 | 15:30 |
| Redemption paid | N/A | T+5 | T+4 | T+2 | T+3 |